Evid Based Nurs 6:76 doi:10.1136/ebn.6.3.76
  • Treatment

Review: regular inhaled long acting β2 agonists are associated with better outcomes than short acting β2 agonists in adults and children with chronic asthma

 QUESTION: What is the effectiveness of regular inhaled long acting β2 agonists compared with inhaled short acting β2 agonists in adults and children with chronic asthma?

Data sources

Studies were identified using the Cochrane Airways Review Group register, which is derived from searching Medline, CINAHL, and EMBASE/Excerpta Medica. In addition, bibliographies of relevant studies were scanned, key respiratory care journals were hand searched, and experts were contacted.

Study selection

Randomised controlled trials of ≥2 weeks duration were selected if they compared a regular inhaled long acting β2 agonist with a regular inhaled short acting β2 agonist of equivalent (as far as possible) bronchodilator effectiveness in adults or children with chronic asthma (ie, those with a diagnosis of ≥6 mo). Studies including participants with other pulmonary …

No Related Web Pages

Free Sample

This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of EBN.
View free sample issue >>

EBN Journal Chat

The EBN Journal Chat offers readers the opportunity to participate in discussion about research articles and commentaries from Evidence Based Nursing (EBN).

How to participate >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article